Literature DB >> 6413386

Unusual response to bifunctional alkylating agents in a case of Fanconi anaemia.

M L Kwee, E H Poll, J J van de Kamp, H de Koning, A W Eriksson, H Joenje.   

Abstract

Chromosomal breakage frequencies were determined in Fanconi anaemia (FA) blood cultures treated with various concentrations of the polyfunctional alkylating agents mitomycin C, diepoxybutane, and cis-platinum(II)-diammine-dichloride, for which FA cells have a characteristic hypersensitivity. At concentrations that hardly affected control cultures, three out of four patients tested exhibited a concentration-dependent increase of cells with aberrant chromosomes, with a concomitant increase in the number of chromosomal aberrations per aberrant cell. The fourth patient, a 22-year-old male, was exceptional because with all three clastogens only 40% of his cultured cells exhibited a typical concentration-dependent response, while 60% of his cells responded like those from normal healthy controls. The possible nature and significance of this unusual response is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6413386     DOI: 10.1007/BF00292372

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  Chromosome preparations of leukocytes cultured from human peripheral blood.

Authors:  P S MOORHEAD; P C NOWELL; W J MELLMAN; D M BATTIPS; D A HUNGERFORD
Journal:  Exp Cell Res       Date:  1960-09       Impact factor: 3.905

2.  Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens.

Authors:  A D Auerbach; S R Wolman
Journal:  Nature       Date:  1976-06-10       Impact factor: 49.962

3.  A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents.

Authors:  M S Sasaki; A Tonomura
Journal:  Cancer Res       Date:  1973-08       Impact factor: 12.701

4.  Fanconi's anaemia in the genetics of neoplasia.

Authors:  M Swift
Journal:  Nature       Date:  1971-04-09       Impact factor: 49.962

5.  Spontaneous chromosomal breakage and high incidence of leukemia in inherited disease.

Authors:  T M Schroeder; R Kurth
Journal:  Blood       Date:  1971-01       Impact factor: 22.113

6.  Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method.

Authors:  A D Auerbach; B Adler; R S Chaganti
Journal:  Pediatrics       Date:  1981-01       Impact factor: 7.124

7.  Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.). I. Clinical aspects.

Authors:  G Fanconi
Journal:  Semin Hematol       Date:  1967-07       Impact factor: 3.851

8.  Mitomycin C test for diagnostic differentiation of idiopathic aplastic anemia and Fanconi anemia.

Authors:  J Cervenka; D Arthur; C Yasis
Journal:  Pediatrics       Date:  1981-01       Impact factor: 7.124

9.  An international system for human cytogenetic nomenclature (1978) ISCN (1978). Report of the Standing Commitee on Human Cytogenetic Nomenclature.

Authors: 
Journal:  Cytogenet Cell Genet       Date:  1978

10.  Proliferative kinetics and mitomycin C-induced chromosome damage in Fanconi's anemia lymphocytes.

Authors:  K Miura; K Morimoto; A Koizumi
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

View more
  11 in total

1.  Fanconi anaemia cells are not uniformly deficient in unhooking of DNA interstrand crosslinks, induced by mitomycin C or 8-methoxypsoralen plus UVA.

Authors:  E H Poll; F Arwert; H T Kortbeek; A W Eriksson
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

2.  DNA semi-conservative synthesis in normal and Fanconi anemia fibroblasts following treatment with 8-methoxypsoralen and near ultraviolet light or with X-rays.

Authors:  E Moustacchi; C Diatloff-Zito
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

3.  Differential sensitivity of Fanconi anaemia lymphocytes to the clastogenic action of cis-diamminedichloroplatinum (II) and trans-diamminedichloroplatinum (II).

Authors:  E H Poll; F Arwert; H Joenje; A H Wanamarta
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

4.  Cytogenetic analyses utilizing various clastogens in two sibs with Fanconi anemia, their relatives, and control individuals.

Authors:  E Gebhart; D Kysela; H Matthee; M Nikol
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair.

Authors:  Miguel A Villalona-Calero; Wenrui Duan; Weiqiang Zhao; Konstantin Shilo; Larry J Schaaf; Jennifer Thurmond; Judith A Westman; John Marshall; Li Xiaobai; Jiuping Ji; Jeffrey Rose; Maryam Lustberg; Tanios Bekaii-Saab; Alice Chen; Cynthia Timmers
Journal:  J Natl Cancer Inst       Date:  2016-02-04       Impact factor: 13.506

6.  Comparison of chromosome breakage in non-mosaic and mosaic patients with Fanconi anemia, relatives, and patients with other inherited bone marrow failure syndromes.

Authors:  John H Fargo; Andrzej Rochowski; Neelam Giri; Sharon A Savage; Susan B Olson; Blanche P Alter
Journal:  Cytogenet Genome Res       Date:  2014-09-11       Impact factor: 1.636

7.  Diagnosis of fanconi anemia: chromosomal breakage analysis.

Authors:  Anneke B Oostra; Aggie W M Nieuwint; Hans Joenje; Johan P de Winter
Journal:  Anemia       Date:  2012-05-24

8.  Diagnostic Overlap between Fanconi Anemia and the Cohesinopathies: Roberts Syndrome and Warsaw Breakage Syndrome.

Authors:  Petra van der Lelij; Anneke B Oostra; Martin A Rooimans; Hans Joenje; Johan P de Winter
Journal:  Anemia       Date:  2010-07-18

9.  Evaluation of concentration and storage effects of mitomycin C in the diagnosis of Fanconi anemia among idiopatic aplastic anemia patients.

Authors:  H Mozdarani; K Abed Ashtiani; A Mohseni-Meybodi
Journal:  Indian J Hum Genet       Date:  2011-09

10.  Diagnosis of Fanconi's Anemia by Diepoxybutane Analysis in Children from Serbia.

Authors:  S Cirkovic; M Guc-Scekic; D Vujic; N Ilic; D Micic; D Skoric; A Jovanovic
Journal:  Balkan J Med Genet       Date:  2011-12       Impact factor: 0.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.